0000-00-00 |
|
|
|
External link to document |
2017-07-06 |
1 |
|
Label (April 2017), # 2 Exhibit B: U.S. Patent No. 9,393,237, # 3 Exhibit C: Actavis ANDA Approved Labeling…2017
31 July 2022
2:17-cv-04964
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |
2017-07-08 |
10 |
|
U.S. Patent No. 9,393,237, # 4 Exhibit 3: U.S. Patent No. 8,658,663, # 5 Exhibit 4: U.S. Patent No. 8,946,251…2017
31 July 2022
2:17-cv-04964
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |
2017-07-10 |
11 |
|
HOLDER or l'ATENT OR TRADEMARK.
I us 9,393,237 7/19/2016 … ~
0 Trademarks or ~Patents. ( O the patent action involves 35 U.S.C. § 292.):
DOCKET…
AO120 Patent Form filed. (jr) (Entered: 07/10/2017)
10 July 2017
PACER Document
… REPORT ON THE
Director of the U.S. Patent and Trademark Office … ACTION REGARDING A PATENT OR
Alexandria, VA 22313 |
External link to document |
2017-07-20 |
22 |
|
paroxetine derivatives are
is disclosed in US 6,063,927. US 6,440,459 and US 2004/0143120 disclose paroxetine…ANDERSEN ET AL.
!S.K./ A15 US-6,063 927 5/16/2000 …issue date of the patent, and will include the patent term adjustment on the
patent. Any request for reconsideration…infringes Plaintiff’s U.S. Patent Nos. 5,874,447 (“’447 patent”); 7,598,271 (“’271 patent”);
8,658,663…,663 (“’663 patent”); and 8,946,251 (“’251 patent”) (collectively “patents-in-suit”) under
35 |
External link to document |
2017-07-25 |
26 |
|
U.S. Patent No. 5,955,475, # 3 Exhibit 35: U.S. Patent No. 6,113,944, # 4 Exhibit 36: U.S. Patent No. …6,645,523, # 5 Exhibit 37: U.S. Patent No. 6,660,298, # 6 Exhibit 38: U.S. Patent No. 6,699,882, # 7 Exhibit…40: U.S. Patent Application Publication No. 2004/0067254 (Lemmens), # 9 Exhibit 41: U.S. Patent No. 6,369,051…2017
31 July 2022
2:17-cv-04964
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |
2017-10-02 |
50 |
|
A: Brisdelle Label, # 2 Exhibit B: U.S. Patent No. 9,393,237, # 3 Exhibit C: Prinston ANDA Approval Letter…2017
31 July 2022
2:17-cv-04964
835 Patent - Abbreviated New Drug Application(ANDA)
Plaintiff |
External link to document |